In September 2020, investigators from the LACOG Head and Neck Cancer Group published the results of the study:  “Health-related quality of life outcomes in head and neck cancer: results from a prospective, real-world data study with Brazilian patients treated with intensity modulated radiation therapy, conformal and conventional radiation techniques” in the well-known scientific periodical, International Journal of Radiation Oncology – Biology – Physics. The study involved 570 Brazilian patients with head or neck cancer and assessed the impact of three different types of radiotherapy: Intensity-Modulated Radiation Therapy (IMRT), conformational radiotherapy and conventional radiotherapy, on patients’ quality of life and overall survival. According to Dr. Marcos Santos, radio-oncologist at the CONFIAR-Goiânia Group and the principal investigator who carried out the study for the group, having a paper accepted for publication shows that Brazil is now playing an active part in producing the real world data that is relied upon by regulatory agencies around the world when making decisions on technology. “It also means that, if we invest in encouraging the use of IMRT to treat head and neck cancer, we can be confident that, depending on the amount, it will be of real help to patients.” The findings of the trial confirm that

It is with great pleasure that we inform that GBCP and LACOG Head and Neck Group are now members of the Head and Neck Cancer International Group.

The CURA Project, of which we are supporters, launched a crowdfunding campaign to support research against head and neck cancer. Join us by supporting the campaign to fund 1,000 laboratory tests and contribute to scientific research. We invite you to join together in this great challenge of raising funds to clinical cancer research community.  Access The CURA Project website and learn more!  Access The Cura Project website

"A multidisciplinary group with 40 representatives from 35 collaborative groups and medical associations developed a consensus practice recommendations for the continuity of care for patients with head and neck cancer during the pandemic, stressing the importance of not interrupting their treatment, treating patients with established protocols, encouraging distance consultations, and adopting protective measures for patients and staff." - Dr. Prof. Luiz P. Kowalski, Vice-chair LACOG Head and Neck Group and A.C. Camargo Center Oncologist Read more on The Lancet website